# Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome

> **NCT00134810** · PHASE2 · COMPLETED · sponsor: **Ipsen** · enrollment: 381 (actual)

## Conditions studied

- Myofascial Pain Syndromes

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT00134810
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2006-05-18
- **Final completion:** 2006-05-18
- **Target enrollment:** 381 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00134810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00134810, "Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00134810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*